Global leader in cancer research is home to LS CancerDiag

Global leader in cancer research is home to LS CancerDiag

Business Finland, the government organization for innovation funding and trade, travel and investment promotion, has published a brochure on ‘Cancer Expertise from Finland’. The digital booklet showcases Finland as a global leader in cancer research and care.

We are delighted that LS CancerDiag is being featured in this digital booklet on Finnish expertise in cancer research and care! You can access or download the PDF version of the booklet here.

The publication lists many of the reasons, why Finland is a leading country in cancer research, such as its healthcare system which is one of the most efficient in the world – offering high value for money spent. It consists of highly educated professionals driving the growth of cutting-edge research and treatment in specialist areas, such as cancer and genetics research.

One objective of cancer research is to develop personalized and effective cancer treatment, especially the utilization of genomic data in diagnostics and treatment selection, and to promote equal and immediate access to clinical examinations for patients. [...] Collaboration between cancer researchers and doctors creates a foundation for evidence-based, multidisciplinary and increasingly individualized care. Based on the average number of citations per clinical cancer publication, Finland is the number one country in cancer research. Each Finnish cancer article receives an average of 26.4 citations.

We are proud of our long-standing collaboration with the Helsinki University Hospital (HUS), which has been key in the development of our DiagMMR® assay and which according to the authors is recognized as a world leader in cancer research and care. As the first hospital in northern Europe awarded the Comprehensive Cancer Centre (CCC) accreditation by the Organization of European Cancer Institutes (OECI), HUS has developed into a nexus of cutting-edge medical research and treatment.

Why Finland?

World-class health research and solutions

Business Finland, Cancer Expertise from Finland, September 2020

LS CancerDiag Logo



Click Here to Learn More

Invest today!

LS CancerDiag has launched a funding round in collaboration with Springvest

The company aims to raise €5.4M in capital to support the expansion into the United States and introduce DiagMMR® to the largest health care market in the world.